3Sbio Inc. (SSRS) SEC Filing 6-K Foreign Issuer report for the period ending Thursday, May 19, 2011

3Sbio Inc.

CIK: 1383790 Ticker: SSRS

View differences made from one to another to evaluate 3Sbio Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 3Sbio Inc..


Assess how 3Sbio Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

3Sbio Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

3Sbio Inc. provided additional information to their SEC Filing as exhibits

Ticker: SSRS
CIK: 1383790
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-11-030079
Submitted to the SEC: Thu May 19 2011 6:02:47 AM EST
Accepted by the SEC: Thu May 19 2011
Period: Thursday, May 19, 2011
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: